Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Atallah

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Physical Chemistry. A|July 11, 2019
Decay-Associated Fourier Spectroscopy: Visible to Shortwave Infrared Time-Resolved Photoluminescence SpectraTimothy L Atallah, Anthony V Sica, Ashley J Shin, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 19, 2024
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States: Real-world asciminib treatment outcomes in CML-CPEhab L Atallah, David Wei, Dominick Latremouille-Viau, et al.
The Journal of Physical Chemistry Letters|January 11, 2023
Spectrally Selective Time-Resolved Emission through Fourier-Filtering (STEF)Anthony V Sica, Ash Sueh Hua, Helen H Lin, et al.
Physiological Measurement|April 19, 2014
Unobtrusive ECG monitoring in the NICU using a capacitive sensing arrayL Atallah, A Serteyn, M Meftah, et al.
Leukemia Research|July 9, 2023
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapySkyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, et al.
Leukemia & Lymphoma|January 23, 2019
Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspectiveEllen K Ritchie, Dominick Latremouille-Viau, Annie Guerin, et al.
Leukemia & Lymphoma|March 2, 2021
Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updatesEhab L Atallah, Islam Sadek, Rodrigo Maegawa, et al.
Nano Letters|January 19, 2021
Large-Area Synthesis and Patterning of All-Inorganic Lead Halide Perovskite Thin Films and HeterostructuresYiliu Wang, Chuancheng Jia, Zheng Fan, et al.
Physical Chemistry Chemical Physics : PCCP|December 16, 2020
Surface chemical trapping of optical cycling centersHan Guo, Claire E Dickerson, Ashley J Shin, et al.
Leukemia Research|September 12, 2025
Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemiaEhab L Atallah, Islam Sadek, David Wei, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Physical Chemistry. A|July 11, 2019
Decay-Associated Fourier Spectroscopy: Visible to Shortwave Infrared Time-Resolved Photoluminescence SpectraTimothy L Atallah, Anthony V Sica, Ashley J Shin, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 19, 2024
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States: Real-world asciminib treatment outcomes in CML-CPEhab L Atallah, David Wei, Dominick Latremouille-Viau, et al.
The Journal of Physical Chemistry Letters|January 11, 2023
Spectrally Selective Time-Resolved Emission through Fourier-Filtering (STEF)Anthony V Sica, Ash Sueh Hua, Helen H Lin, et al.
Physiological Measurement|April 19, 2014
Unobtrusive ECG monitoring in the NICU using a capacitive sensing arrayL Atallah, A Serteyn, M Meftah, et al.
Leukemia Research|July 9, 2023
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapySkyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, et al.
Leukemia & Lymphoma|January 23, 2019
Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspectiveEllen K Ritchie, Dominick Latremouille-Viau, Annie Guerin, et al.
Leukemia & Lymphoma|March 2, 2021
Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updatesEhab L Atallah, Islam Sadek, Rodrigo Maegawa, et al.
Nano Letters|January 19, 2021
Large-Area Synthesis and Patterning of All-Inorganic Lead Halide Perovskite Thin Films and HeterostructuresYiliu Wang, Chuancheng Jia, Zheng Fan, et al.
Physical Chemistry Chemical Physics : PCCP|December 16, 2020
Surface chemical trapping of optical cycling centersHan Guo, Claire E Dickerson, Ashley J Shin, et al.
Leukemia Research|September 12, 2025
Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemiaEhab L Atallah, Islam Sadek, David Wei, et al.
Pageof 5